Skip to Content

What are the clinical benefits of Exondys 51?

Answers (1)

Official Answer by Drugs.com 30 Nov 2016

Exondys 51 (eteplirsen) was the first drug FDA-approved for Duchenne Muscular Dystrophy (DMD), and was cleared under accelerated approval.

Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.

Exondys 51 was approved under the FDA accelerated approval pathway for serious or life-threatening diseases based on the surrogate endpoint of dystrophin increase in skeletal muscle observed in some patients.

A clinical benefit of Exondys 51, including improved motor function, has not yet been established.

Additional studies are being conducted by the manufacturer, Sarepta Therapeutics, to fully confirm the drug’s clinical benefit.

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What are the active ingredients in Qtern?

Posted 5 Jul 2017 1 answerFAQ by Drugs.com

What is the Siliq REMS Program?

Posted 5 Jul 2017 1 answerFAQ by Drugs.com

What type of drug is Emflaza?

Posted 5 Jul 2017 1 answerFAQ by Drugs.com

What is Parsabiv used to treat?

Posted 5 Jul 2017 1 answerFAQ by Drugs.com

Is Xyzal available over-the-counter?

Posted 5 Jul 2017 1 answerFAQ by Drugs.com